Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Bharmal
Using Convergent Mixed Methods to Evaluate Treatment Risks and Benefits in Rare Disease: An Example From a Phase Ii Registration Trial in Metastatic Merkel Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Treatment–subgroup Interaction: An Example From a Published, Phase II Clinical Trial
Contemporary Clinical Trials
Medicine
Pharmacology
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial
Oncologist
Cancer Research
Medicine
Oncology
Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
Journal of Skin Cancer
Dermatology
Oncology
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
